Calling it a "major step forward," the Consumer Healthcare Products Association (CHPA) commended the House of Representatives on passing HR 5280, the Dextromethorphan Distribution Act. Reps Fred Upton (R, Mich) and Rick Larsen (D, Wash) developed and introduced the legislation.
The law prohibits the distribution of raw dextromethorphan, an active ingredient commonly found in OTC cough medicines, to any individuals other than the FDA-registered producers of drugs and devices. "This bipartisan legislation is vital to protecting America's youth from unscrupulous on-line pushers who willingly provide kids with the raw form of dextromethorphan as a means to get high," said Linda A. Suydam, DPA, president of CHPA.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs